Clinical Trial

Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 26, 2026 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This clinical trial wants to find out if the Virtual Far-sight Reading Device can help prevent or slow down myopia progression in children and teenagers with pre-myopia. We also want to know what makes this treatment work better for some participants and check for any eye or body-related side effects over time. Main questions: Can using the Virtual Far-sight Reading Device reduce the risk of myopia? Is the device safe to use every day for up to 6 months? What we'll do: Researchers will compare two groups of children: Group A: Uses the device for reading/writing (at least 1 hour daily) Group B: Does regular reading/writing without the device After 90 days, the groups will switch to see if the results stay the same. Participants will: * Have free eye checkups 3 times over 6 months * Use the device during homework time (if in the desk group) * Report any eye discomfort or problems
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-21.
Status change: Not Yet Recruiting → Recruiting 2026-05-21
Trial Details
NCT Number NCT06995911
Lead Sponsor Shanghai Eye Disease Prevention and Treatment Center
Conditions Myopia, Pre-myopia
Enrollment 80 participants
Start Date 2025-06-01
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-26